Aurora Cannabis (NASDAQ:ACB) Posts Quarterly Earnings Results, Beats Estimates By $0.15 EPS

Aurora Cannabis (NASDAQ:ACB) announced its quarterly earnings results on Wednesday. The company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.15, Zacks reports. Aurora Cannabis had a negative net margin of 17.47% and a negative return on equity of 2.19%.

Aurora Cannabis Stock Up 46.7 %

Aurora Cannabis stock traded up $1.72 during midday trading on Wednesday, hitting $5.40. 37,816,741 shares of the stock were exchanged, compared to its average volume of 2,240,929. Aurora Cannabis has a 1 year low of $2.84 and a 1 year high of $9.35. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.83 and a quick ratio of 1.88. The firm has a market cap of $296.24 million, a P/E ratio of -7.06 and a beta of 1.85. The company has a 50 day moving average price of $4.19 and a two-hundred day moving average price of $5.16.

Analyst Ratings Changes

ACB has been the subject of several analyst reports. TD Securities raised Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th. TD Cowen assumed coverage on Aurora Cannabis in a report on Wednesday, December 11th. They issued a “buy” rating for the company.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.